Potential Risk of Device Component Breaking

Recommendations for patients, caregivers, and health care providers

If your email program has trouble displaying this email, view as a webpage. Risk of Device Component Breaking in Patients with STAR Ankle Replacement The U.S. Food and Drug Administration (FDA) is advising patients, caregivers, and health care providers about the higher than expected rate of device component fracture associated with the Scandinavian Total Ankle Replacement (STAR Ankle) device. This means a part of the STAR Ankle device is more likely to break than what was expected based on previous information. This safety communication includes: Recommendations for patients, caregivers, and health care providers. Summary of the long-term post-approval study results and Medical Device Reports for STAR Ankle Replacements. Instructions for reporting to the FDA any problems with this device. Read the Safety Communication Questions? If you have questions about this safety communication, contact the Division of Industry and Consumer Education (DICE).

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA